Simplifying Global Compliance
Edwards Looks to Pipeline After U.S. Sapien Sales Miss Slightly
Edwards’ U.S. sales for its Sapien transcatheter heart valve were slightly lower sequentially in the third quarter, a factor that will likely “continue to fuel concerns around the barriers to adoption,” Leerink Swann analyst Danielle Antalffy says.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing